Showing 12,141 - 12,160 results of 20,124 for search '(( 50 ((ms decrease) OR (nn decrease)) ) OR ( 100 ((a decrease) OR (we decrease)) ))', query time: 0.76s Refine Results
  1. 12141

    Acoustics of breath noises in human speech (Werner et al., 2024) by Raphael Werner (17350943)

    Published 2024
    “…</p><p dir="ltr"><b>Results: </b>For human inhalations, we found spectra with a decreasing slope and several weak peaks below 3 kHz. …”
  2. 12142

    Quantitative Venn diagram of proteins expressed in sera of patients with clinically significant portal hypertension (CSPH) and non-CSPH group. by Frane Pastrovic (18349349)

    Published 2024
    “…Abbreviations: ATX–Autotaxin; BPI–Bactericidal permeability increasing protein; CAT–Catalase; CD44 –Cluster of differentiation 44; FN1 –Fibronectin; HIST1H2BN–Histone H2B; HIST1H4A –Histone H4; LYVE1 –Lymphatic vessel endothelial hyaluronic acid receptor 1; MPO–Myeloperoxidase; NPNT–Nephronectin; PAI-1 –Plasminogen activator inhibitor 1; PRDX2 –Peroxiredoxin-2; S100-A9—Protein S100-A9.…”
  3. 12143

    Image_3_Compound small peptide of Chinese medicine alleviates cyclophosphamide induced immunosuppression in mice by Th17/Treg and jejunum intestinal flora.JPEG by Yuqing Cui (1529068)

    Published 2023
    “…<p>The aim of this study was to explore the efficacy of Compound small peptide of Chinese medicine (CSPCM) on cyclophosphamide (CTX) induced immunosuppression in mice. The 100 male Kunming mice were divided into 5 groups: group A (control group), group B (model group), group C (100 mg/kg.bw CSPCM), group D (200 mg/kg.bw CSPCM) and group E (400 mg/kg.bw CSPCM). …”
  4. 12144

    Effects of the mutant L29Q cTnC and SD cTnI determined by Molecular Dynamics simulations. by Alison Y. Li (486146)

    Published 2013
    “…The Ca<sup>2+</sup> ion bound in site II is shown as a black sphere. (C) shows the largest movement caused by the L29Q mutation in the presence of the pseudo-phosphorylated cTnI, which is the re-orientation of helix A and helix B of cNTnC accompanied by a decrease of interhelical angle of 13°.…”
  5. 12145

    Small-diameter sensory neurons from mutant mice have relatively few deficits in chemical activation. by Katherine J. Zappia (3178827)

    Published 2016
    “…<p>(<b>A</b>) Calcium imaging of small-diameter DRG neurons revealed no difference in the percentage of neurons responding to the 100 μM of the TRPA1 agonist, cinnamaldehyde, when comparing control and mutant neurons. …”
  6. 12146

    Image_1_Compound small peptide of Chinese medicine alleviates cyclophosphamide induced immunosuppression in mice by Th17/Treg and jejunum intestinal flora.JPEG by Yuqing Cui (1529068)

    Published 2023
    “…<p>The aim of this study was to explore the efficacy of Compound small peptide of Chinese medicine (CSPCM) on cyclophosphamide (CTX) induced immunosuppression in mice. The 100 male Kunming mice were divided into 5 groups: group A (control group), group B (model group), group C (100 mg/kg.bw CSPCM), group D (200 mg/kg.bw CSPCM) and group E (400 mg/kg.bw CSPCM). …”
  7. 12147

    Relationship between functional disability and costs one and two years post stroke by Ingrid Lekander (3910180)

    Published 2017
    “…</p><p>Method</p><p>Resource use during first and second year following a stroke was estimated based on a research database containing linked data from several registries. …”
  8. 12148

    GPR39-expressing cells. by Fanning Zeng (124301)

    Published 2012
    “…Shown are ratiometric images of Ca<sup>2+</sup> signals before and after 100 µM Zn<sup>2+</sup> challenge. [Ca<sup>2+</sup>]<i><sub>i</sub></i> is indicated on a rainbow scale with blue representing low [Ca<sup>2+</sup>]<i><sub>i</sub></i> and orange/red high [Ca<sup>2+</sup>]<i><sub>i</sub></i>. …”
  9. 12149

    Electrophoretic mobility shift assay showing the interaction of wild type TsTBP1 with Ts2-CysPrx TATA-box probe. by Oscar Rodríguez-Lima (821378)

    Published 2015
    “…B) The densitometric analysis shows a decrease on the intensity of shifted bands in homologous and heterologous competition. …”
  10. 12150

    Electrophoretic mobility shift assay showing the interaction of wild type TsTBP1 pAT5 TATA-box probe. by Oscar Rodríguez-Lima (821378)

    Published 2015
    “…B) Densitometric analysis shows a decrease on the intensity of shifted bands in homologous and heterologous competition. …”
  11. 12151

    Supplementary Material for: Burden of Neurological disorders in children and adolescents (<20 years old) in North Africa and the Middle East (NAME) from 1990 to 2021 by figshare admin karger (2628495)

    Published 2025
    “…Idiopathic epilepsy remained a leading cause of mortality, although it had a decrease of -50.9% in YLLs compared to 1990. …”
  12. 12152

    Healthy control group HR and CBF changes. by Liuchuang Wei (19273099)

    Published 2025
    “…Computational results revealed that hypovolemia reduces cerebral blood flow by approximately 100 mL/min due to a 30% decrease in blood volume, while vascular dysfunction—marked by a 50–100% increase in arterial stiffness—further diminishes cardiac output and cerebral perfusion. …”
  13. 12153

    Image_2_Compound small peptide of Chinese medicine alleviates cyclophosphamide induced immunosuppression in mice by Th17/Treg and jejunum intestinal flora.JPEG by Yuqing Cui (1529068)

    Published 2023
    “…<p>The aim of this study was to explore the efficacy of Compound small peptide of Chinese medicine (CSPCM) on cyclophosphamide (CTX) induced immunosuppression in mice. The 100 male Kunming mice were divided into 5 groups: group A (control group), group B (model group), group C (100 mg/kg.bw CSPCM), group D (200 mg/kg.bw CSPCM) and group E (400 mg/kg.bw CSPCM). …”
  14. 12154

    List of abbreviations used in this paper. by Liuchuang Wei (19273099)

    Published 2025
    “…Computational results revealed that hypovolemia reduces cerebral blood flow by approximately 100 mL/min due to a 30% decrease in blood volume, while vascular dysfunction—marked by a 50–100% increase in arterial stiffness—further diminishes cardiac output and cerebral perfusion. …”
  15. 12155

    Estimation of the CO and CBF. by Liuchuang Wei (19273099)

    Published 2025
    “…Computational results revealed that hypovolemia reduces cerebral blood flow by approximately 100 mL/min due to a 30% decrease in blood volume, while vascular dysfunction—marked by a 50–100% increase in arterial stiffness—further diminishes cardiac output and cerebral perfusion. …”
  16. 12156

    DataSheet_1_Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling of cetagliptin in patients with type 2 diabetes mellitus.docx by Chen Zhou (466781)

    Published 2024
    “…Compared with placebo group, plasma active GLP-1 AUEC<sub>0-24h</sub> increased by 2.20- and 3.36-fold in the 50 mg and 100 mg cetagliptin groups. A decrease of plasma glucose and increase of insulin and C-peptide were observed following OGTT in cetagliptin groups. …”
  17. 12157

    Cdk2 and PTPLAD1 interact with IR complex organization. by Martial Boutchueng-Djidjou (5832626)

    Published 2018
    “…<p>(A) HEK293 cells were transfected with pcDNA3-Cdk2 (T) or pcDNA3 (NT) for 48 hours. …”
  18. 12158

    Activation of AMPK prevented drug-induced hepatocellular injury and hepatocyte depolarization. by Sun Woo Sophie Kang (3280878)

    Published 2016
    “…After hepatocytes were treated with various concentrations of acetaminophen (APAP) or diclofenac (Diclo), dose-viability response curves were obtained for (<b>A</b>) acetaminophen (1–20mM, 24hr) in rat hepatocytes, (<b>B</b>) diclofenac (50–800μM, 24hr) in rat hepatocytes, (<b>C</b>) acetaminophen (1–50mM, 24hr) in human hepatocytes, and (<b>D</b>) diclofenac (100–3000μM, 24hr) in human hepatocytes. …”
  19. 12159
  20. 12160

    Nefopam inhibits cell viability in cultures from aggressive fibromatosis and hypertrophic cutaneous wounds. by Raymond Poon (12265)

    Published 2013
    “…The mean value for the cell culture treated with carrier was arbitrarily defined as 100 for each cell type. A) Data for a dose of 10 µM of Nefopam. …”